Direct Lung Tissue Morphogenesis via Controlled Cellular and Matrix Interactions

Abstract

Effective tissue engineering requires recreating the orchestrated interactions between cells and their surrounding cellular and extracellular matrix environments. Research in our group investigates how these interactions drive lung tissue morphogenesis. This talk will highlight our recent efforts to direct apicobasal polarity and lineage diversification in lung epithelia through controlled presentation of matrix and stromal cues, as well as strategies for shaping tissue geometry using bioprinting. We will also discuss the potential applications of these engineered tissue systems in therapeutic development and delivery.

Bio

Dr. Ren is currently an Associate Professor of Biomedical Engineering at Carnegie Mellon University. Dr. Ren received his B.S. in Biological Sciences and Ph.D. in Cell Biology, both from Peking University. He completed his post-doctoral training in tissue engineering at Harvard Medical School. Current research in his lab focuses on understanding and engineering lung and vascular tissue morphogenesis, and are funded by grants from the NSF, NIH, DoD, ARPA-H, and private foundations. Dr. Ren received the NSF CAREER Award, Rising Star Award from the Biomedical Engineering Society, Biomedical Engineering New Innovator Award from the Northeast Bioengineering Conference, and was named Dean’s Early Career Fellow by the College of Engineering at Carnegie Mellon University. He serves on the Young Investigator Committee at the Cell Transplant and Regenerative Medicine Society, and on the Publication Committee at the American Society of Matrix Biology.

Related Info

Register Now

Steve Henikoff, PhD

Professor of Basic Sciences - Fred Hutchinson Cancer Center, Seattle

Abstract

Genome-wide hypertranscription is common in human cancer and predicts poor prognosis. To understand how hypertranscription might drive cancer, we applied our CUTAC method for mapping RNA polymerase II (RNAPII) genome-wide in formalin-fixed paraffin-embedded (FFPE) sections. RNAPII occupancy at S-phase-dependent histone genes accurately predicted rapid recurrence of meningiomas and corresponded to total whole-arm chromosome losses. Whole-arm losses alone predicted outcome in RNA-sequencing and whole-genome pan-cancer sequencing data. We propose that elevated RNAPII at histone genes both drives hyper-proliferation and displaces the CENP-A histone H3 variant from centromeres, causing centromere breaks and aneuploidies that shape the selective landscape in cancer progenitor cells. Our experimental investigation of the S-phase-dependent histone genes in flies and humans has uncovered a negative feedback loop that regulates histone gene expression over the cell cycle.

Register Here

About Steve Henikoff

Steve Henikoff received a BS from the University of Chicago, a PhD from Harvard University and performed post-doctoral work at the University of Washington. He is a professor of Basic Sciences at Fred Hutch, and an affiliate professor of Genome Sciences at the University of Washington. He is also an HHMI investigator, a member of the US National Academy of Sciences and a fellow of both the American Academy of Arts and Sciences and the American Association for the Advancement of Science. He received the Genetics Society of America Medal in 2015, and the 55th Lewis S. Rosenstiel Award for Distinguished Work in Basic Medical Research in 2025. His laboratory performs research on chromatin and nuclear dynamics, transcriptional regulation, centromeres and cancer epigenetics, and develops experimental and computational tools for studying these processes.

Sponsored by the Center for Physical Genomics and Engineering, the Cancer and Physical Sciences Program at the Robert H. Lurie Comprehensive Cancer Center, and NIH Grants T32GM142604 and U54CA268084

Related Info

Register Now

Bringing Microfluidics into the Clinic: Lessons from COVID19 and Cancer

Abstract

Dr. Stott will share her laboratory’s work using microfluidics to isolate cell-specific extracellular vesicles in cancer and infectious disease applications alongside a new approach to isolate extracellular vesicles from urine.

Bio

Professor Stott is a biomedical engineer that works at the interface of technology and clinical medicine. She has an extensive background in microfluidics, optics, and biopreservation, with a focus on applications in cancer and infectious diseases. Manipulating blood flow for the isolation of biological components has been a hallmark of her work and recent efforts include using microfluidics to separate cancer cells and extracellular vesicles. The primary goal of the Stott laboratory is to use these technologies to improve patient lives through early diagnosis and a greater understanding of how cancer spreads and kills.

Dr. Stott has >25 patents issued or pending, and her research has been highlighted in Nature, Science, CNN, MIT Technology Review, as well as the television show, Jeopardy. She serves on various advisory boards, both in academic and industrial settings. Dr. Stott has been awarded many different honors, but she is most proud of receiving the 2021 MGH Excellence in Mentorship Award.

Related Info

Register Now